Di Napoli, Raffaella https://orcid.org/0009-0009-4497-3836
Richez, Christophe
Scavone, Cristina
Singier, Allison
Demourgues, Maxime
Mascolo, Annamaria
Capuano, Annalisa
Salvo, Francesco
Funding for this research was provided by:
Università degli Studi della Campania Luigi Vanvitelli
Article History
Accepted: 17 February 2025
First Online: 23 March 2025
Change Date: 22 June 2025
Change Type: Update
Change Details: The original article has been corrected. The author's name Maxime Demourgues is corrected in the original publication and the statement in Discussion section is corrected.
Change Date: 22 April 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40264-025-01552-7
Change Date: 23 June 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40264-025-01578-x
Declarations
:
: Open access funding provided by Università degli Studi della Campania Luigi Vanvitelli within the CRUI-CARE Agreement. No funding supported this research.
: The authors declare no conflict of interest, except Francesco Salvo, who is a member of the Editorial Board of Drug Safety. Francesco Salvo did not participate in the selection of peer reviewers for this manuscript or in any subsequent editorial decisions.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Access to VigiBase and VigiLyze is managed directly by the Uppsala Monitoring Centre ().
: Conceptualization, F.S. and. A.C; formal analysis, investigation, and methodology R.D.N.; supervision, A.M., C.C., C.R., A.S., M.D.; validation, F.S. and A.C., writing original draft, R.D.N.; writing review and editing, F.S. and C.R. All authors have read and agreed to the published version of the manuscript.